Medtronic Contributes to OSU’s $63M Neuroscience Technology Development Project

Medtronic and Cardinal Health have partnered with Ohio State University in Columbus to provide $42 million in funding for neuroscience technology development, according to a Mass Device report.

Advertisement

The university is still looking for an additional $21 million in state funds through Third Frontier. OSU filed a letter of intent with the Ohio Development Services Agency and named the project a $63 million model for creating multiple commercial companies, called the Neurotechnology Innovations Translator.

Minneapolis-based Medtronic currently has no locations in Ohio.

More Articles on Devices: 
Exactech CEO William Petty Sells 10k Stock Shares for $236,700
AxoGen Partner With Burleston, Texas to Open Distribution Facility
Device Companies — 6 Key Notes — NuVasive, Smith & Nephew, Aurora Spine & More

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.